VILCHEMIE M 1000

About

VILCHEMIE M 1000 is a combination medication used for the treatment of type 2 diabetes mellitus, containing Vildagliptin and Metformin. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones (GLP-1 and GIP) in the body. These hormones enhance glucose-dependent insulin secretion from pancreatic beta cells and suppress glucagon secretion from alpha cells, leading to improved blood glucose control without a high risk of hypoglycemia. Metformin, a biguanide, reduces hepatic glucose production, improves insulin sensitivity, and decreases intestinal glucose absorption.

This combination therapy offers a synergistic approach to managing type 2 diabetes by addressing both impaired insulin secretion and insulin resistance, as well as post-meal glucose excursions. VILCHEMIE M 1000 is typically prescribed when diet, exercise, and monotherapy with either Vildagliptin or Metformin are insufficient to achieve target blood sugar levels. It provides effective glycemic control with a relatively low risk of weight gain and hypoglycemia, making it a valuable option for many patients.

Uses

• Management of type 2 diabetes mellitus.
• To improve glycemic control in adults.
• Used as an adjunct to diet and exercise.
• When monotherapy is inadequate.

Directions For Use

Take this medicine orally with food, as directed by your physician. Swallow the tablet whole with a glass of water.

Benefits

• Effective blood sugar control.
• Reduces fasting and post-meal glucose.
• Low risk of hypoglycemia (compared to sulfonylureas).
• Does not typically cause weight gain.
• Improves insulin sensitivity.
• Convenient combination therapy.

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Headache
• Dizziness
• Nasopharyngitis
• Tremor
• Lactic acidosis (rare but serious)
• Vitamin B12 deficiency
• Joint pain
• Fatigue
• Peripheral edema

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it can increase the risk of lactic acidosis (Metformin) and affect blood sugar levels.
• Pregnancy - Not recommended during pregnancy due to insufficient safety data. Consult your doctor for alternative treatments.
• Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk. Seek medical advice.
• Liver - Use with caution in patients with liver impairment. Liver function tests should be monitored before and during treatment, especially with Vildagliptin.
• Kidney - Contraindicated in severe kidney impairment (Metformin). Dose adjustment for Metformin and Vildagliptin may be needed for moderate impairment.
• Lung - Generally safe for use in patients with stable lung conditions. However, severe respiratory conditions leading to hypoxia can increase lactic acidosis risk.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.